Topical Cysteamine
Sponsors
Chang Gung Memorial Hospital, UnionDerm
Conditions
Hyperpigmentation; PostinflammatoryMelasma
Unknown Phase
Efficacy and Safety of Topical Cysteamine for Postinflammatory Hyperpigmentation
NCT05206318
Start: 2021-12-10End: 2022-12-10Target: 40Updated: 2022-01-25
Combination Topical Cysteamine and Fractional 1927nm Low-Powered Diode Laser for Treatment of Facial Melasma
NCT05656833
Start: 2022-10-28End: 2023-07-31Target: 20Updated: 2022-12-19